DEMEETRA AGBIO

demeetra-agbio-logo

Demeetra AgBio is the issuance of licenses for agriculture, industrial biotechnology, and pharmaceutical bioprocessing.

#People #Website #More

DEMEETRA AGBIO

Social Links:

Industry:
Agriculture Biotechnology Market Research Pharmaceutical

Founded:
2019-01-01

Address:
Lexington, Kentucky, United States

Country:
United States

Website Url:
http://www.demeetra.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Content Delivery Network Global Site Tag Yoast WordPress SEO Plugin GoDaddy SSL GoDaddy WooCommerce Checkout BbPress Active Campaign PowerPack For Beaver Builder WooCommerce 4.6


Current Employees Featured

jack-crawford_image

Jack Crawford
Jack Crawford Chief Executive Officer @ Demeetra AgBio
Chief Executive Officer
2019-01-01

kevin-slawin_image

Kevin Slawin
Kevin Slawin Board Member @ Demeetra AgBio
Board Member
2020-10-01

Official Site Inspections

http://www.demeetra.com Semrush global rank: 1.02 M Semrush visits lastest month: 33.31 K

  • Host name: 79.0.153.160.host.secureserver.net
  • IP address: 160.153.0.79
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Demeetra AgBio"

Gene Editing Technologies - Demeetra

Demeetra AgBio holds exclusive licenses to gene editing technologies Cas-CLOVER and piggyBac transposase for research and commercial fields in agriculture, industrial biotech and โ€ฆSee details»

Demeetra AgBio - Crunchbase Company Profile & Funding

Demeetra AgBio is the issuance of licenses for agriculture, industrial biotechnology, and pharmaceutical bioprocessing. View contacts for Demeetra AgBio to access new leads and โ€ฆSee details»

Commercial licenses with freedom to operate - Demeetra

Demeetra AgBio, Inc., holds the exclusive licenses for the gene editing technologies Cas-CLOVER and piggyBac transposase, for use in research and commercial applications in โ€ฆSee details»

Demeetra Company Profile 2024: Valuation, Funding

Demeetra General Information Description. Developer of gene-editing technology designed for research and commercial fields in agriculture, industrial biotech, โ€ฆSee details»

Demeetra - LinkedIn

Demeetra | 456 followers on LinkedIn. Gene Editing Without Limits: Freedom To Operate. Guided Expertise. | Centrally located in the Bluegrass State of Kentucky, Demeetra has built extensive โ€ฆSee details»

Demeetra AgBio, Inc. - BIO International Convention | BIO

Jun 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Demeetra โ€ฆSee details»

Demeetra AgBio - Crunchbase

Demeetra AgBio is the issuance of licenses for agriculture, industrial biotechnology, and pharmaceutical bioprocessing.See details»

Demeetra | Cell & Gene Therapy International

Demeetra provides solutions to the biggest challenges facing our clients when adopting CRISPR & transposase technology for commercial cell line development. By combining our own Cas โ€ฆSee details»

Demeetra AgBio - Updates, News, Events, Signals & Triggers

Demeetra AgBio may be growing as the company is associated with Cas-CLOVER, an advanced gene editing technology that is highlighted for its capability to meet crop improvement โ€ฆSee details»

Jack Crawford - Demeetra | Cell & Gene Therapy International โ€ฆ

Jack Crawford is the founding CEO of Demeetra. As CEO, Jack is focused on providing partners with commercially applicable gene editing technologies through simple accessible licenses. โ€ฆSee details»

CRISPR Medicine News Interview with Demeetra AgBio CEO, Jack โ€ฆ

Jun 14, 2021 Demeetra Agbio, a Rapha portfolio company was recently featured in an article in the leading industry publication, CRISPR News MEDICINE. Demeetra AgBio, headquartered โ€ฆSee details»

ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing โ€ฆ

Sep 14, 2023 Demeetra, headquartered in Kentucky, is a biotechnology company whose core focus is developing and optimizing gene editing technologies in commercially applicable โ€ฆSee details»

Company: Demeetra AgBio - CRISPR Medicine

Demeetra Agbio is a privately held agricultural and therapeutic gene-editing company. Based in Kentrucky, US, the company utilises its proprietary Cas-CLOVER platform to genetically โ€ฆSee details»

Demeetra AgBio Advances Major Pipeline for Therapeutic

Jun 16, 2021 Demeetra is advancing a pipeline of therapeutic cannabinoids and plans to file an IND in Q1 of 2022 for its lead candidate. ... Organization Profile. Demeetra AgBio. Contact โ€ฆSee details»

As FDA considers Cutting Nicotine in Cigarettes, Demeetra

Jun 15, 2021 Demeetra AgBio is open for licensing and services to modify any tobacco strain, variety, or other crop with its precise gene editing technology. ... Organization Profile. โ€ฆSee details»

Jack Crawford's lab - ResearchGate

At Demeetra AgBio, our mission is to advance gene editing in plants, yeast and CHO cells for biotherapeutic manufacturing and crop trait development. We are working to optimize our โ€ฆSee details»

Demeetraโ€™s Complementary Gene Editing Technologies

Jun 10, 2024 Demeetra is a biotechnology company specializing in gene editing technologies with commercial freedom to operate. Our extensive expertise complements both our internally โ€ฆSee details»

โ€œthe clean alternative to CRISPR/Cas9โ€ with Cas-CLOVER

Demeetra developed a proprietary method protocol which is transferred to our licensees and partners 6 New protocol yields 90%+ genome editing efficiency and white shoots/total shoots โ€ฆSee details»

Designing Cas-CLOVER: a dimeric RNA guided targeted - Demeetra

Www.demeetra.com Figure 3: Cas-CLOVER KO ef๏ฌciency at different gap lengths Clo051-G4S-dCas Clo051-(G4S)โ‚„-dCas Demeetra only provides the Cas-CLOVER mRNA as a reagent and โ€ฆSee details»

Demeetra (@DemeetraAgbio) / Twitter

Mar 26, 2020 Demeetraโ€™s advanced gene editing technology enables researchers to make targeted knockouts and insertions. This scarless gene editing means no heterologous genes โ€ฆSee details»